Negative regulation of cyclic AMP levels by activation of cyclic nucleotide phosphodiesterases: the example of the dog thyroid.
D015056:1-Methyl-3-isobutylxanthine / Q000494:pharmacology; D015105:3',5'-Cyclic-AMP Phosphodiesterases / Q000378:metabolism*; D000109:Acetylcholine / Q000494:pharmacology; D000262:Adenylyl Cyclases / Q000378:metabolism; D000818:Animals; D002118:Calcium / Q000494:pharmacology; D002217:Carbachol / Q000494:pharmacology; D000242:Cyclic AMP / Q000378:metabolism*; D015237:Dinoprost; D004285:Dogs; D004533:Egtazic Acid / Q000494:pharmacology; D004789:Enzyme Activation; D066298:In Vitro Techniques; D011460:Prostaglandins F / Q000494:pharmacology; D013961:Thyroid Gland / Q000187:drug effects / Q000201:enzymology*
D011460:Prostaglandins F; D004533:Egtazic Acid; D002217:Carbachol; D015237:Dinoprost; D000242:Cyclic AMP; D015105:3',5'-Cyclic-AMP Phosphodiesterases; D000262:Adenylyl Cyclases; D000109:Acetylcholine; D002118:Calcium; D015056:1-Methyl-3-isobutylxanthine